Collegium Pharmaceutical Inc

Ticker COLL

Exchange NASDAQ More
Industry Drugs - Generic More
Sector Healthcare More

201-500 Employees
Based in Canton, Massachusetts

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (165)

Collegium Pharmaceutical Inc reports have an aggregate usefulness score of 4.8 based on 165 reviews.

Collegium Pharmaceutical Inc

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Collegium Pharmaceutical Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.